Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 59
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Y-DNA A00 and the Peoples of Cameroon: In Search of the Homeland

    This was the first phase of our fundraising campaign to support our fieldwork in Cameroon. We were very...

    Where are endangered California least terns spending their winters?

    Wintering habitats of California least terns remain unknown, despite having terns being listed as endangered...

    Backer Badge Funded